Sector: MedicalMedicines Company (The) (NASDAQ: MDCO)
Headlines
- The Medicines Company Reports Third Quarter 2009 Financial Results
Oct 28, 2009 08:01 AM | MDCO
- The Medicines Company Announces Positive CHMP Opinion for Angiox(R) (Bivalirudin) for Use in Heart Attack Patients Undergoing Emergency Heart Procedures
Oct 23, 2009 09:29 AM | MDCO
- BioMed News Bytes: Antigenics, King, Shire, Delcath
Oct 21, 2009 10:37 AM | AGEN, CRL, DCTH, MDCO, SHPGY
- McKesson (NYSE: MCK): Healthcare Winner
Oct 16, 2009 11:00 AM | MCK, MDCO
- The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635
Oct 15, 2009 04:30 PM | MDCO
- BioMed News Bytes: PGNX, SMTS, ZIOP, CXM, PSDV, BMTI
Oct 14, 2009 12:36 PM | AMD, BMTI, MDCO, PFS, PGNX, SMTS
- Tongjitang Chinese Medicines Repurchases 19.3 Million Ordinary Shares in Private Transactions
Oct 12, 2009 04:01 PM | MDCO, TCM
- The Medicines Company Files Patent Infringement Lawsuits
Oct 08, 2009 05:05 PM | MDCO
- The Medicines Company Announces Second New Patent Issuance for Angiomax(R)
Oct 08, 2009 08:01 AM | MDCO
- The Next Big Thing In Health Care: How To Profit From Immunotherapy & Regenerative Medicine
Oct 07, 2009 03:27 PM | BBI, BMRN, BMY, CVM, CYTX, DNA
- RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on LGF, AZ, MW, R, MDCO and LPNT
Sep 28, 2009 08:07 AM | AZ, LGF, LPNT, MDCO, MW, R
- The Medicines Company Announces New Patent Issuance for Angiomax(R)
Sep 02, 2009 07:51 AM | MDCO
- The Medicines Company Withdraws European Marketing Application for 3-7 Day Daily Dose Oritavancin Therapy
Aug 20, 2009 05:00 PM | MDCO
- The Medicines Company Announces Option Grants Under Nasdaq Marketplace Rule 5635
Aug 14, 2009 05:05 PM | MDCO
- The Medicines Company Responds to Incorrect News Reports
Aug 10, 2009 07:00 AM | MDCO
- The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635
Jul 31, 2009 04:30 PM | MDCO
- The Medicines Company Reports Second Quarter 2009 Financial Results
Jul 29, 2009 08:01 AM | MDCO
- The Medicines Company Appoints T. Scott Johnson as Vice President, New Business Ventures & Chief Medical Advisor
Jul 23, 2009 06:00 PM | MDCO
- The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635
Jul 15, 2009 05:00 PM | MDCO
- The Medicines Company to Announce Second Quarter 2009 Financial Results on Wednesday, July 29, 2009
Jul 15, 2009 04:30 PM | MDCO
- Form 4 MEDICINES CO /DE For: Aug 31 Filed by: SBLENDORIO GLENN (10K)
Sep 01, 2009 07:35 PM
- Form 4 MEDICINES CO /DE For: Aug 31 Filed by: MEANWELL CLIVE (10K)
Sep 01, 2009 07:19 PM
- Form 4 Antinori Paul Michael For: Aug 31 (10K)
Sep 01, 2009 07:19 PM
- Form 4 MEDICINES CO /DE For: Jul 21 Filed by: JOHNSON T SCOTT (10K)
Jul 23, 2009 08:51 PM
- Form 4 WYATT ELIZABETH H S For: May 28 (10K)
May 29, 2009 08:28 PM
- Form 4 Spigelman Melvin K For: May 28 (10K)
May 29, 2009 08:26 PM
- Form 4 Shigeta Hiroaki For: May 28 (10K)
May 29, 2009 08:25 PM
- Form 4 KESSLER ARMIN M For: May 28 (10K)
May 29, 2009 08:25 PM
- Form 4 Savage Robert G. For: May 28 (10K)
May 29, 2009 08:23 PM
- Form 4 MEDICINES CO /DE For: May 28 Filed by: JOHNSON T SCOTT (10K)
May 29, 2009 08:10 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MDCO
|
Compare to S&P
|
| YTD |
-51.19 %
|
-57.45 %
|
| 4 Weeks |
-31.33 %
|
-32.06 %
|
| 12 Weeks |
-10.13 %
|
-12.35 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -185.71 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: -5.17 %
|
|
Sales Growth in Last Quarter: 12.10 %
|
|
